| Active ingredient (INN) | Itraconazole |
|---|---|
| Brand names | Sporanox |
| Therapeutic category | Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | SANDOZ LIMITED, FOCUS PHARMACEUTICALS LIMITED, ACCORD HEALTHCARE LIMITED, LABORATORIOS LICONSA SA +7 more |
| Registrations on file | 18 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| ITRACONAZOLE 100 MG CAPSULES, HARD | 100 MG | capsule | 🇬🇧 GB | SANDOZ LIMITED | Active |
| ITRACONAZOLE 10 MG/ML ORAL SOLUTION | 10 MG | solution | 🇬🇧 GB | FOCUS PHARMACEUTICALS LIMITED | Active |
| Accord Healthcare Limited Itraconazole | 100MG | capsule | 🇬🇧 GB | ACCORD HEALTHCARE LIMITED | Active |
| Itraconazole100 Mg | 100 MG | capsule | 🇬🇧 GB | LABORATORIOS LICONSA SA | Active |
| ITRACONAZOLE 10MG/ML SUGAR FREE ORAL SOLUTION | 10MG | solution | 🇬🇧 GB | SYRI LIMITED | Active |
| ITRACONAZOLE 10 MG/ML CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION | 10 MG | solution | 🇬🇧 GB | NEON HEALTHCARE LIMITED | Active |
| SPORANOX itraconazole | 10 mg | — | 🇦🇺 AU | Janssen-Cilag Pty Ltd | Active |
| LOZANOC itraconazole | 50 mg | — | 🇦🇺 AU | Mayne Pharma International Pty Ltd | Active |
| Gxp | 100 mg | — | 🇦🇺 AU | — | Active |
| Genpar | 100 mg | — | 🇦🇺 AU | — | Active |
| SPORAZOLE itraconazole | 100 mg | — | 🇦🇺 AU | — | Active |
| ITRANOX itraconazole | 100 mg | — | 🇦🇺 AU | — | Active |
| SPINOX itraconazole | 100 mg | — | 🇦🇺 AU | — | Active |
| ITRACAP itraconazole | 100 mg | — | 🇦🇺 AU | — | Active |
| Gppl | 100 mg | — | 🇦🇺 AU | — | Active |